Detalhe da pesquisa
1.
Metabolic Profiling as an Approach to Differentiate T-Cell Acute Lymphoblastic Leukemia Cell Lines Belonging to the Same Genetic Subgroup.
Int J Mol Sci
; 25(7)2024 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-38612731
2.
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Br J Haematol
; 200(4): 440-450, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36335916
3.
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Blood
; 138(9): 773-784, 2021 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33876209
4.
Comparison between Sickle Cell Disease Patients and Healthy Donors: Untargeted Lipidomic Study of Erythrocytes.
Int J Mol Sci
; 24(3)2023 Jan 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36768849
5.
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine.
Curr Opin Oncol
; 34(6): 738-747, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36017547
6.
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma.
Blood
; 135(19): 1685-1695, 2020 05 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32315407
7.
Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement.
Ann Hematol
; 101(2): 297-307, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34859285
8.
MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
Genes Chromosomes Cancer
; 60(7): 482-488, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33611795
9.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Haematologica
; 106(6): 1559-1568, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32467145
10.
The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling.
Blood
; 129(4): 460-472, 2017 01 26.
Artigo
Inglês
| MEDLINE | ID: mdl-27683414
11.
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Haematologica
; 107(4): 996-999, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35021604
12.
Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations.
Blood
; 124(24): 3577-82, 2014 Dec 04.
Artigo
Inglês
| MEDLINE | ID: mdl-25270907
13.
Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.
Haematologica
; 101(8): 951-8, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27151989
14.
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Haematologica
; 101(8): 941-50, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27151993
15.
Cryptic 13q34 and 4q35.2 Deletions in an Italian Family.
Cytogenet Genome Res
; 147(1): 24-30, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26645620
16.
New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia.
Blood
; 121(25): 5064-7, 2013 Jun 20.
Artigo
Inglês
| MEDLINE | ID: mdl-23673860
17.
Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.
Haematologica
; 100(10): 1301-10, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26206799
18.
A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T-cell acute lymphoblastic leukemia.
Am J Hematol
; 95(12): E335-E338, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32936972
19.
Molecular Cytogenetics Detect an Unbalanced t(2;13)(q36;q14) and PAX3-FOXO1 Fusion in Rhabdomyosarcoma With Mixed Embryonal/Alveolar Features.
Pediatr Blood Cancer
; 62(12): 2238-41, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26179572
20.
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia.
Hemasphere
; 8(3): e51, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38463444